Dose-dense weekly docetaxel and CBDCA in adriamycin-resistant metastatic breast cancer (MBC)

被引：5
|
作者：
Salimi, M [1 ]
Mir, MR [1 ]
机构：
[1] Mehr Hosp, Iranian Canc Inst, Tehran, Iran
来源：
EUROPEAN JOURNAL OF CANCER | 1998年 / 34卷
关键词：
D O I：
10.1016/S0959-8049(98)80167-6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
178
引用
收藏
页码：S44 / S44
页数：1
相关论文
共 50 条
  • [1] A phase I study of dose-dense docetaxel (D) with cyclophosphamide (C) as first line in patients (pts) with metastatic breast cancer (MBC).
    Hocini, H
    Cottu, P
    Cuvier, C
    Romieux, G
    Culine, S
    Lerebours, F
    Espie, M
    Boccara, C
    Marty, M
    ANNALS OF ONCOLOGY, 2000, 11 : 24 - 24
  • [2] Weekly application of docetaxel in patients with previously treated metastatic breast cancer (MBC).
    Krapfl-Gast, AS
    Grischke, EM
    Bastert, G
    ANNALS OF ONCOLOGY, 2000, 11 : 30 - 30
  • [3] Fixed dose, dose-dense capecitabine in metastatic breast cancer.
    O'Dea, Anne
    Khan, Meshaal
    Haines, Haley Isabela
    Kimler, Bruce F.
    Nye, Lauren Elizabeth
    Sharma, Priyanka
    Khan, Qamar J.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [4] Phase I trial of dose-dense docetaxel and doxorubicin with or without sargramostim in patients with metastatic breast cancer
    Montero A.
    Booser D.
    Esparza-Guerra L.
    Murray J.
    Rosales M.
    Hortobagyi G.
    Valero V.
    Drugs in R & D, 2005, 6 (5) : 299 - 305
  • [5] Dose-dense therapy with weekly 1-hour paclitaxel infusions in the treatment of metastatic breast cancer
    Seidman, AD
    Hudis, CA
    Albanel, J
    Tong, W
    Tepler, I
    Currie, V
    Moynahan, ME
    Theodoulou, M
    Gollub, M
    Baselga, J
    Norton, L
    JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (10) : 3353 - 3361
  • [6] Reduced dose of Capecitabine and Docetaxel in treatment of metastatic breast cancer (MBC)
    Iravani, Masood
    ANNALS OF ONCOLOGY, 2004, 15 : 46 - 46
  • [7] Weekly dose-dense chemotherapy for ovarian cancer
    Tanday, Sanjay
    LANCET ONCOLOGY, 2016, 17 (04): : E138 - E138
  • [8] Dose-Dense Docetaxel versus Weekly Paclitaxel following Dose-Dense Epirubicin and Cyclophosphamide as Adjuvant Chemotherapy in Node-Positive Breast Cancer Patients: A Retrospective Cohort Analysis
    Khoshroo, Sara
    Sandoughdaran, Saleh
    Sabetrasekh, Parisa
    Hajian, Parastoo
    Bikdeli, Pegah
    Sabetrasekh, Parto
    Nasrollahi, Fatemeh
    Yeganeh, Ladan Mohammadi
    Naeini, Sepideh Jafari
    Mirzaei, Hamid Reza
    INTERNATIONAL JOURNAL OF BREAST CANCER, 2021, 2021
  • [9] Adjuvant dose-dense sequential chemotherapy with epirubicin, CMF, and weekly docetaxel is feasible and safe in patients with operable breast cancer
    George Fountzilas
    Dimitrios Pectasides
    Christos Christodoulou
    Eleni Timotheadou
    Theofanis Economopoulos
    Pavlos Papakostas
    Christos Papadimitriou
    Helen Gogas
    Ioannis Efstratiou
    Dimosthenis Skarlos
    Medical Oncology, 2006, 23 : 479 - 488
  • [10] Adjuvant dose-dense sequential chemotherapy with epirubicin, CMF, and weekly docetaxel is feasible and safe in patients with operable breast cancer
    Fountzilas, George
    Pectasides, Dimitrios
    Christodoulou, Christos
    Timotheadou, Eleni
    Economopoulos, Theofanis
    Papakostas, Pavlos
    Papadimitriou, Christos
    Gogas, Helen
    Efstratiou, Ioannis
    Skarlos, Dimosthenis
    MEDICAL ONCOLOGY, 2006, 23 (04) : 479 - 488
12345